Search All News
Longtime awardee and faculty partner of the Irving Institute will lead the multi-institutional BioHub.
Source:Columbia Zuckerman Institute
Irving Scholar Elizabeth Hillman, PhD, and her team received a $24 million UM1 center grant and a $150 million BRAIN CONNECTS initiative for new ambitious project.
TRx Awardee, Dr. Zev Williams, directs the Columbia Fertility Center leading the discovery of new painless fertility treatment
Dr. Monk joins 20 leaders across the country who will transform systems so that all children and families can thrive.
Source:CUIMC NewsroomOctober 26, 2023
Each investigator will receive a grant of $200,000 over five years to conduct novel high-risk, high-reward research that furthers new scientific knowledge, with the goal of improving patient care.
- October 16, 2023
Eight research teams led by Columbia University faculty, across diverse disciplines, have received a Columbia Life Science Accelerator Pilot Grant for their innovative lab-to-market projects.
- October 10, 2023
Irving Institute UL1 cited in study on impact of pre-existing psychiatrics conditions on COVID-19 outcomes.
Source:New York TimesOctober 10, 2023
Dr. Jason D. Wright, 2011 Irving Scholar, leads one of the first studies quantifying age groups of those receiving gender affirming care.
Source:CNN HealthOctober 9, 2023
Dr. David Ho, 2011 Irving Institute pilot awardee, leads the team at Columbia University lab supporting these findings.
Source:CUIMC NewsroomOctober 9, 2023
New study by Dritan Agalliu, PhD, Irving Institute Bench to Bedside Pilot Awardee, and David Sulzer, PhD, adds to this hypothesis.
Source:CUIMC NewsroomSeptember 26, 2023
Dr. Alex Dranovsky, Irving Scholar and TRx Pilot Awardee, leads new study on the role of neurogenesis in memory loss.
Source:CUIMC NewsroomAugust 31, 2023
Mildred Embree, MD, Irving Institute awardee, recently published a study about the Osteoarthritis drug developed in her lab.
Source:CNNAugust 17, 2023
Dr. Jennifer Manly, one of Irving Institute's 2022 Senior Mentors of the Year, weighs in on the efficacy of new Alzheimer's drug, donanemab, that may be approved in the US this year.
- July 6, 2023
The Irving Institute for Clinical and Translational Research is honored to announce four new Herbert and Florence Irving Scholars for the 2023-2026 cohort.